Incyte Announces Updated Presentation Time for Upcoming Investor Conference

Audio By Carbonatix

WILMINGTON, Del.--(BUSINESS WIRE)--Nov 26, 2024--

Incyte (Nasdaq:INCY) announced today that it will now present at Citi’s 2024 Global Healthcare Conference on Tuesday, December 3, 2024 at 8:00 a.m.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241126113474/en/

CONTACT: Incyte

Media

[email protected]

[email protected]

KEYWORD: DELAWARE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Incyte

Copyright Business Wire 2024.

PUB: 11/26/2024 04:10 PM/DISC: 11/26/2024 04:10 PM

http://www.businesswire.com/news/home/20241126113474/en